Skip to main content

Peer Review reports

From: Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China

Original Submission
23 Jan 2018 Submitted Original manuscript
25 Jan 2018 Author responded Author comments - Jian Sun
Resubmission - Version 2
25 Jan 2018 Submitted Manuscript version 2
11 Feb 2018 Reviewed Reviewer Report - Florian MAYER
25 Feb 2018 Reviewed Reviewer Report - Andreas Maieron
3 Mar 2018 Reviewed Reviewer Report - Michael Gschwantler
8 Jun 2018 Author responded Author comments - Jian Sun
Resubmission - Version 3
8 Jun 2018 Submitted Manuscript version 3
7 Sep 2018 Reviewed Reviewer Report - Andreas Maieron
13 Sep 2018 Reviewed Reviewer Report - Florian MAYER
21 Sep 2018 Reviewed Reviewer Report - Michael Gschwantler
23 Nov 2018 Author responded Author comments - Jian Sun
Resubmission - Version 4
23 Nov 2018 Submitted Manuscript version 4
30 Dec 2018 Reviewed Reviewer Report - Michael Gschwantler
18 Mar 2019 Author responded Author comments - Jian Sun
Resubmission - Version 5
18 Mar 2019 Submitted Manuscript version 5
1 Apr 2019 Author responded Author comments - Jian Sun
Resubmission - Version 6
1 Apr 2019 Submitted Manuscript version 6
Publishing
8 Apr 2019 Editorially accepted
2 May 2019 Article published 10.1186/s12876-019-0981-5

You can find further information about peer review here.

Back to article page